Clinical Trial Update: Albumin-bound Paclitaxel Plus S-1 Versus SOX as First-line Treatment in Advanced or Recurrent Gastric Adenocarcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing albumin-bound paclitaxel plus S-1 versus SOX as first-line therapy for advanced or recurrent gastric adenocarcinoma is in early status w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Albumin-bound paclitaxel (nab-paclitaxel)
• S-1 (tegafur/gimeracil/oteracil)
• SOX (SOX)

Snippet

Sponsor: Huazhong University of Science and Technology | Conditions: Gastric Cancer | Phase 3 | Status: UNKNOWN